Literature DB >> 20132489

Analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease using Fourier (spectral) analysis.

R A Armstrong1, N J Cairns.   

Abstract

AIM: To determine the spatial pattern of beta-amyloid (Abeta) deposition throughout the temporal lobe in Alzheimer's disease (AD).
METHODS: Sections of the complete temporal lobe from six cases of sporadic AD were immunolabelled with antibody against Abeta. Fourier (spectral) analysis was used to identify sinusoidal patterns in the fluctuation of Abeta deposition in a direction parallel to the pia mater or alveus.
RESULTS: Significant sinusoidal fluctuations in density were evident in 81/99 (82%) analyses. In 64% of analyses, two frequency components were present with density peaks of Abeta deposits repeating every 500-1000 microm and at distances greater than 1000 microm. In 25% of analyses, three or more frequency components were present. The estimated period or wavelength (number of sample units to complete one full cycle) of the first and second frequency components did not vary significantly between gyri of the temporal lobe, but there was evidence that the fluctuations of the classic deposits had longer periods than the diffuse and primitive deposits.
CONCLUSIONS: (i) Abeta deposits exhibit complex sinusoidal fluctuations in density in the temporal lobe in AD; (ii) fluctuations in Abeta deposition may reflect the formation of Abeta deposits in relation to the modular and vascular structure of the cortex; and (iii) Fourier analysis may be a useful statistical method for studying the patterns of Abeta deposition both in AD and in transgenic models of disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20132489      PMCID: PMC2972722          DOI: 10.1111/j.1365-2990.2010.01071.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  35 in total

Review 1.  What does the study of the spatial patterns of pathological lesions tell us about the pathogenesis of neurodegenerative disorders?

Authors:  R A Armstrong; N J Cairns; P L Lantos
Journal:  Neuropathology       Date:  2001-03       Impact factor: 1.906

2.  Analysis of spatial patterns in histological sections of brain tissue using a method based on regression.

Authors:  R A Armstrong
Journal:  J Neurosci Methods       Date:  2000-01-31       Impact factor: 2.390

Review 3.  Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer's disease.

Authors:  C B Saper; B H Wainer; D C German
Journal:  Neuroscience       Date:  1987-11       Impact factor: 3.590

4.  The blood-brain barrier in Alzheimer's disease.

Authors:  H V Vinters; W M Pardridge
Journal:  Can J Neurol Sci       Date:  1986-11       Impact factor: 2.104

5.  Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.

Authors:  R C Pearson; M M Esiri; R W Hiorns; G K Wilcock; T P Powell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  Extracellular amyloid formation and associated pathology in neural grafts.

Authors:  Melanie Meyer-Luehmann; Martina Stalder; Martin C Herzig; Stephan A Kaeser; Esther Kohler; Michelle Pfeifer; Sonia Boncristiano; Paul M Mathews; Marc Mercken; Dorothee Abramowski; Matthias Staufenbiel; Mathias Jucker
Journal:  Nat Neurosci       Date:  2003-04       Impact factor: 24.884

7.  Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease.

Authors:  A Delacourte; N Sergeant; D Champain; A Wattez; C-A Maurage; F Lebert; F Pasquier; J-P David
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

8.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-08-16       Impact factor: 3.575

Review 9.  Quantifying the pathology of neurodegenerative disorders: quantitative measurements, sampling strategies and data analysis.

Authors:  R A Armstrong
Journal:  Histopathology       Date:  2003-06       Impact factor: 5.087

Review 10.  What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?

Authors:  Richard A Armstrong; Peter L Lantos; Nigel J Cairns
Journal:  Neuropathology       Date:  2008-04-23       Impact factor: 1.906

View more
  1 in total

1.  Disturbance of phylogenetic layer-specific adaptation of human brain gene expression in Alzheimer's disease.

Authors:  Natasha Andressa Nogueira Jorge; Uwe Ueberham; Mara Knobloch; Peter F Stadler; Jörg Fallmann; Thomas Arendt
Journal:  Sci Rep       Date:  2021-10-12       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.